Skip to main content

About ISR

The pharmaceutical industry’s source for high-quality market research.

Our industry reports utilize primary market research, which enables us to provide our customers with novel data on topics that, until now, were only attainable through custom research.

View Library

For our custom research services, we leverage years of industry experience and a global proprietary Health Panel of over 3,000 healthcare and pharmaceutical professionals to provide our customers with endless innovative possibilities.

Learn More

What makes ISR different?

We understand that you’re looking for confidence in your market research. With ISR, you’ll consistently receive…

Focused Domain Expertise

We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.

Genuine Research Expertise

Our market research experience has developed over 20 years in many dynamic industries. We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and give you confidence in your decisions.

Transparency

If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data and suspect contacts instead of real decision makers. We deliver the opinions, attitudes, and recommendations of industry experts – and we’ll prove it by sharing detailed demographics in our reports.

Insights from our research

Articles

Highly Potent API Manufacturing

Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…
Articles

Commercial Bioprocessing Market Outlook

Choosing an outsourcing partner for a commercial bioprocessing endeavor carries a gravitas that those outside that endeavor may not appreciate. Equally significant is the challenge facing CMOs in this space, many of whom are competing against larger, well-known manufacturers with…
Articles

Cell & Gene Market Outlook

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…